home / stock / bfra / bfra quote
Last: | $2.67 |
---|---|
Change Percent: | -9.49% |
Open: | $3.1 |
Close: | $2.67 |
High: | $3.1 |
Low: | $2.6 |
Volume: | 4,951 |
Last Trade Date Time: | 03/04/2022 04:54:38 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.67 | $3.1 | $2.67 | $3.1 | $2.6 | 4,951 | 03-04-2022 |
$2.95 | $3.08 | $2.95 | $3.08 | $2.79 | 3,676 | 03-03-2022 |
$2.91 | $2.64 | $2.91 | $2.91 | $2.58 | 4,048 | 03-02-2022 |
$2.92 | $2.9025 | $2.92 | $2.92 | $2.6901 | 4,682 | 03-01-2022 |
$2.83 | $2.8 | $2.83 | $3.2999 | $2.65 | 11,340 | 02-28-2022 |
$2.93 | $2.89 | $2.93 | $3.3566 | $2.89 | 30,109 | 02-25-2022 |
$2.92 | $2.94 | $2.92 | $2.96 | $2.56 | 10,854 | 02-24-2022 |
$2.92 | $2.75 | $2.92 | $3.09 | $2.65 | 16,546 | 02-23-2022 |
$2.73 | $3.14 | $2.73 | $3.14 | $2.68 | 11,034 | 02-22-2022 |
$3.11 | $2.95 | $3.11 | $3.18 | $2.93 | 5,713 | 02-21-2022 |
$3.11 | $2.95 | $3.11 | $3.18 | $2.93 | 5,713 | 02-18-2022 |
$2.95 | $3.02 | $2.95 | $3.2499 | $2.92 | 18,956 | 02-17-2022 |
$3.12 | $3 | $3.12 | $3.24 | $2.92 | 15,726 | 02-16-2022 |
$2.9 | $2.84 | $2.9 | $3.2 | $2.82 | 38,387 | 02-15-2022 |
$2.76 | $3.24 | $2.76 | $3.24 | $2.0906 | 135,629 | 02-14-2022 |
$3.28 | $3.2401 | $3.28 | $3.425 | $3.2401 | 7,313 | 02-11-2022 |
$3.46 | $3.52 | $3.46 | $3.6499 | $3.4262 | 17,133 | 02-10-2022 |
$3.6 | $3.4 | $3.6 | $3.68 | $3.24 | 222,829 | 02-09-2022 |
$2.98 | $2.9 | $2.98 | $3.16 | $2.9 | 5,347 | 02-08-2022 |
$2.78 | $2.85 | $2.78 | $2.85 | $2.78 | 3,575 | 02-07-2022 |
News, Short Squeeze, Breakout and More Instantly...
Biofrontera AG Company Name:
BFRA Stock Symbol:
NASDAQ Market:
Leverkusen, Germany, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Biofrontera AG (the “Company”) (Nasdaq: BFRA; Frankfurt Stock Exchange: B8F), an international biopharmaceutical company, decided today its American Depositary Shares (“ADS”) should be delisted from the N...
Leverkusen, Germany, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (ISIN: DE0006046113) has been in mediation proceedings with Mr. Wilhelm K. T. Zours and Deutsche Balaton AG for a year in order to find a solution for the settlement of legal ...
Leverkusen, Germany, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its financial results for the nine months ended September 30, 2021. K ...